Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Tables)

6 Months Ended

Jul. 03, 2022

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earning Per Share

The following presents the detailed calculation of EPS:
	Three Months Ended				Six Months Ended
(MILLIONS)	July 3, 2022		July 4, 2021		July 3, 2022		July 4, 2021
EPS Numerator––Basic
Income from continuing operations attributable to Pfizer Inc. common shareholders	$	9,871	$	5,799	$	17,743	$	10,675
Discontinued operations––net of tax	34		(236)		26		(235)
Net income attributable to Pfizer Inc. common shareholders	$	9,906	$	5,563	$	17,769	$	10,440
EPS Numerator––Diluted
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions	$	9,871	$	5,799	$	17,743	$	10,675
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions	34		(236)		26		(235)
Net income attributable to Pfizer Inc. common shareholders and assumed conversions	$	9,906	$	5,563	$	17,769	$	10,440
EPS Denominator
Weighted-average number of common shares outstanding––Basic	5,593		5,598		5,605		5,591
Common-share equivalents: stock options and stock issuable under employee compensation plans	119		80		130		79
Weighted-average number of common shares outstanding––Diluted	5,712		5,678		5,735		5,670
Anti-dilutive common stock equivalents(a)	1		5		—		4

(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.